JP2023116739A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023116739A5 JP2023116739A5 JP2023100171A JP2023100171A JP2023116739A5 JP 2023116739 A5 JP2023116739 A5 JP 2023116739A5 JP 2023100171 A JP2023100171 A JP 2023100171A JP 2023100171 A JP2023100171 A JP 2023100171A JP 2023116739 A5 JP2023116739 A5 JP 2023116739A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- hinge region
- peptide according
- seq
- helical domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762448358P | 2017-01-19 | 2017-01-19 | |
| US62/448,358 | 2017-01-19 | ||
| US201762476535P | 2017-03-24 | 2017-03-24 | |
| US201762476531P | 2017-03-24 | 2017-03-24 | |
| US62/476,531 | 2017-03-24 | ||
| US62/476,535 | 2017-03-24 | ||
| PCT/US2018/014532 WO2018136803A1 (en) | 2017-01-19 | 2018-01-19 | Apoc-ii mimetic peptides |
| JP2019539809A JP7353973B2 (ja) | 2017-01-19 | 2018-01-19 | Ａｐｏｃ－ｉｉ模倣ペプチド |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019539809A Division JP7353973B2 (ja) | 2017-01-19 | 2018-01-19 | Ａｐｏｃ－ｉｉ模倣ペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023116739A JP2023116739A (ja) | 2023-08-22 |
| JP2023116739A5 true JP2023116739A5 (enExample) | 2023-12-05 |
Family
ID=62908746
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019539809A Active JP7353973B2 (ja) | 2017-01-19 | 2018-01-19 | Ａｐｏｃ－ｉｉ模倣ペプチド |
| JP2023100171A Pending JP2023116739A (ja) | 2017-01-19 | 2023-06-19 | Ａｐｏｃ－ｉｉ模倣ペプチド |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019539809A Active JP7353973B2 (ja) | 2017-01-19 | 2018-01-19 | Ａｐｏｃ－ｉｉ模倣ペプチド |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11136372B2 (enExample) |
| EP (1) | EP3571216A4 (enExample) |
| JP (2) | JP7353973B2 (enExample) |
| KR (1) | KR102700862B1 (enExample) |
| CN (1) | CN110831957B (enExample) |
| AU (1) | AU2018210404B2 (enExample) |
| BR (1) | BR112019014707A2 (enExample) |
| CA (1) | CA3050106A1 (enExample) |
| IL (2) | IL268093B2 (enExample) |
| MX (1) | MX2019008529A (enExample) |
| NZ (1) | NZ755599A (enExample) |
| SG (2) | SG11201906422VA (enExample) |
| TW (2) | TWI788323B (enExample) |
| WO (1) | WO2018136803A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018136803A1 (en) | 2017-01-19 | 2018-07-26 | The United States Of America, As Represented By The Secretary Departmetn Of Health & Human Services | Apoc-ii mimetic peptides |
| CN117580857A (zh) * | 2021-06-23 | 2024-02-20 | 美国政府(由卫生和人类服务部的部长所代表) | Apoc-ii短模拟肽及使用方法 |
| WO2023215838A1 (en) * | 2022-05-05 | 2023-11-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Short apolipoprotein e mimetic peptides and methods of use |
| EP4565251A1 (en) * | 2022-08-07 | 2025-06-11 | Protean Bio, Inc. | Peptides for beta-cell survival and insulin production |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US6156727A (en) * | 1996-09-05 | 2000-12-05 | Uab Research Foundation | Anti-atherosclerotic peptides and a transgenic mouse model of antherosclerosis |
| MXPA04002848A (es) | 2001-09-28 | 2005-06-06 | Esperion Therapeutics Inc | Prevencion y tratamiento de restenosis por administracion local de medicamento. |
| US7220576B2 (en) * | 2002-01-07 | 2007-05-22 | Lifesensors, Inc. | Methods and compositions for protein expression and purification |
| CA2512879A1 (en) * | 2003-01-17 | 2004-08-12 | Soumya P. Sahoo | N-cyclohexylaminocarbonyl benzenesulfonamide derivatives |
| WO2005058938A2 (en) * | 2003-12-15 | 2005-06-30 | The Regents Of The University Of California | Helical synthetic peptides that stimulate cellular cholesterol efflux |
| US7691860B2 (en) * | 2004-02-19 | 2010-04-06 | Banyu Pharmaceutical Co., Ltd. | Sulfonamide derivatives |
| US7569546B2 (en) * | 2004-07-16 | 2009-08-04 | Trustees Of Tufts College | Apolipoprotein A1 mimetics and uses thereof |
| AU2006263332B2 (en) * | 2005-06-29 | 2012-02-23 | Hadasit Medical Research Services & Development Ltd. | Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes |
| US20080138284A1 (en) * | 2006-09-26 | 2008-06-12 | Lipid Sciences, Inc. | Novel Peptides That Promote Lipid Efflux |
| WO2009097584A1 (en) * | 2008-01-30 | 2009-08-06 | Proteogenix, Inc. | Maternal serum biomarkers for detection of pre-eclampsia |
| WO2009129263A1 (en) * | 2008-04-15 | 2009-10-22 | The Government Of The Usa As Represented By The Secretary Of The Department Of Health & Human Serv. | Peptides promoting lipid efflux via abca1 and activating a lipoprotein lipase |
| EP2484692A4 (en) | 2009-09-30 | 2013-03-06 | Snu R&Db Foundation | MIMETIC APOLIPOPROTEIN A-1-PEPTIDES AND THERAPEUTICS FOR THE TREATMENT OF HYPERLIPIDEMIA AND DISEASES RELATED TO HYPERLIPIDEMIA THEREWITH |
| BR112015010276A2 (pt) | 2012-11-06 | 2019-10-15 | Hoffmann La Roche | peptídeos miméticos |
| WO2018136803A1 (en) | 2017-01-19 | 2018-07-26 | The United States Of America, As Represented By The Secretary Departmetn Of Health & Human Services | Apoc-ii mimetic peptides |
| EA201991491A1 (ru) | 2017-03-24 | 2019-12-30 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сервисис | Миметические пептиды apoc-ii |
-
2018
- 2018-01-19 WO PCT/US2018/014532 patent/WO2018136803A1/en not_active Ceased
- 2018-01-19 SG SG11201906422VA patent/SG11201906422VA/en unknown
- 2018-01-19 BR BR112019014707A patent/BR112019014707A2/pt unknown
- 2018-01-19 US US16/479,183 patent/US11136372B2/en active Active
- 2018-01-19 JP JP2019539809A patent/JP7353973B2/ja active Active
- 2018-01-19 CN CN201880019604.7A patent/CN110831957B/zh active Active
- 2018-01-19 MX MX2019008529A patent/MX2019008529A/es unknown
- 2018-01-19 AU AU2018210404A patent/AU2018210404B2/en active Active
- 2018-01-19 EP EP18742118.5A patent/EP3571216A4/en active Pending
- 2018-01-19 IL IL268093A patent/IL268093B2/en unknown
- 2018-01-19 SG SG10201911974UA patent/SG10201911974UA/en unknown
- 2018-01-19 NZ NZ755599A patent/NZ755599A/en unknown
- 2018-01-19 TW TW107102123A patent/TWI788323B/zh active
- 2018-01-19 KR KR1020197024024A patent/KR102700862B1/ko active Active
- 2018-01-19 TW TW109138699A patent/TW202130652A/zh unknown
- 2018-01-19 CA CA3050106A patent/CA3050106A1/en active Pending
-
2020
- 2020-12-29 IL IL279831A patent/IL279831A/en unknown
-
2021
- 2021-03-09 US US17/195,766 patent/US11827690B2/en active Active
-
2023
- 2023-06-19 JP JP2023100171A patent/JP2023116739A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023116739A5 (enExample) | ||
| AU784845B2 (en) | Cell-permeable peptide inhibitors of the JNK signal transduction pathway | |
| JP2003503312A5 (enExample) | ||
| JP2013545724A5 (enExample) | ||
| JP2023156353A5 (enExample) | ||
| CA2370289A1 (en) | Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides | |
| IL192046A (en) | Intact and peptide intestinal fragments and methods of use | |
| CN101490081A (zh) | 用于抑制神经元nmda受体(nmdar)与nmdar相互作用蛋白的相互作用的融合肽 | |
| JP2011518179A5 (enExample) | ||
| CA2945838C (en) | Modified relaxin b chain peptides | |
| JP2015504052A5 (enExample) | ||
| US20140080758A1 (en) | Treatment of kidney disorders with vip fragments | |
| JPWO2019156137A5 (enExample) | ||
| RU2014131605A (ru) | Пептидные антагонисты пептидных гормонов из семейства кальцитонина (cgrp) и их применение | |
| JP2007535910A5 (enExample) | ||
| AU2016277449B2 (en) | Protease-resistant lipidated GLP-1 analogs | |
| JP2020511425A5 (enExample) | ||
| US20230340022A1 (en) | Compounds and methods for treating tight junction permeability | |
| EP2089419A2 (en) | Inhibition of beta-amyloid aggregation | |
| JP2002539829A5 (enExample) | ||
| JPWO2016063969A1 (ja) | ヘマグルチニン結合ペプチド | |
| JP2002529474A (ja) | 高分子量キニノゲン及びそのペプチド類似体による血管形成の抑制 | |
| JP2015506960A5 (enExample) | ||
| JP2006523181A5 (enExample) | ||
| JP2009503092A5 (enExample) |